Published in Malar J on February 05, 2015
Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? Malar J (2016) 0.76
Anti-malarial effect of semi-synthetic drug amitozyn. Malar J (2015) 0.75
Amodiaquine and Ciprofloxacin Combination in Plasmodiasis Therapy. J Trop Med (2015) 0.75
Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream? Antimicrob Agents Chemother (2017) 0.75
1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS. J Med Pharm Chem (1962) 13.97
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Artemisinins target the SERCA of Plasmodium falciparum. Nature (2003) 7.72
Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother (2003) 7.09
Primaquine therapy for malaria. Clin Infect Dis (2004) 4.66
New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov (2009) 4.00
Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother (2004) 2.50
The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol (1970) 2.08
Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance. Exp Parasitol (1965) 2.01
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg (2012) 1.97
The origins of antimalarial drug resistance. Trends Parasitol (2004) 1.57
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
The quinolones: past, present, and future. Clin Infect Dis (2005) 1.48
Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis (2012) 1.38
Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent. Biochem Pharmacol (2008) 1.35
Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc Natl Acad Sci U S A (2012) 1.34
In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother (2003) 1.16
Cell division in apicomplexan parasites. Nat Rev Microbiol (2014) 1.15
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. Proc Biol Sci (2010) 1.02
Targeting the liver stage of malaria parasites: a yet unmet goal. J Med Chem (2011) 0.96
Ciprofloxacin treatment of drug-resistant falciparum malaria. J Infect Dis (1991) 0.93
Antimalarial activity of newly synthesized chalcone derivatives in vitro. Chem Biol Drug Des (2012) 0.92
In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum. Am J Trop Med Hyg (2008) 0.90
Recent progress in the development of anti-malarial quinolones. Malar J (2014) 0.90
Plasmodium: resistance to antimalarial drugs. Ann Parasitol Hum Comp (1990) 0.89
Antiplasmodial interactions between artemisinin and triclosan or ketoconazole combinations against blood stages of Plasmodium falciparum in vitro. Am J Trop Med Hyg (2007) 0.85
Ciprofloxacin and malaria. Lancet (1988) 0.85
Norfloxacin: a new drug in the treatment of falciparum malaria. Ann Intern Med (1989) 0.84
In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone. Acta Trop (2000) 0.84
Activities of pefloxacin and ciprofloxacin against experimental malaria in mice. Antimicrob Agents Chemother (1990) 0.81
Synthesis and in vitro antiplasmodial activities of fluoroquinolone analogs. Eur J Med Chem (2012) 0.78